{"gene":"TPO","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1995,"finding":"TPO (thrombopoietin) binding to c-Mpl induces tyrosine phosphorylation and activation of STAT5 and STAT3, defining a rapid JAK-STAT signaling pathway downstream of the TPO receptor.","method":"Immunoprecipitation, electrophoretic mobility shift assay (EMSA), tyrosine phosphorylation assays in hematopoietic cell lines","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP and functional assays, replicated alongside JAK2 activation findings","pmids":["7544303"],"is_preprint":false},{"year":1995,"finding":"TPO/c-mpl signaling induces tyrosine phosphorylation of JAK2, Shc, Sos (Ras pathway components), Vav, and c-Cbl, indicating activation of both JAK/STAT and Ras signaling pathways downstream of c-Mpl.","method":"Tyrosine phosphorylation assays and immunoprecipitation in Mo7e megakaryoblastic cells","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — direct biochemical assays with multiple substrates identified, consistent with parallel studies","pmids":["7488109"],"is_preprint":false},{"year":1998,"finding":"TPO knockout and c-mpl knockout mice show 90% reduction in platelets due to reduced hematopoietic progenitor numbers and decreased megakaryocyte ploidy; circulating TPO levels are regulated by platelet mass through c-Mpl-mediated binding and uptake, establishing a feedback mechanism for TPO homeostasis.","method":"Genetic knockout mouse models, bone marrow analysis, platelet counts, repopulation assays","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, replicated in two independent gene-targeted mouse lines","pmids":["9474742"],"is_preprint":false},{"year":2004,"finding":"The adaptor protein Lnk negatively regulates TPO/c-Mpl signaling; Lnk overexpression attenuates TPO-induced STAT3, STAT5, Akt, and MAPK activation, and Lnk deficiency results in enhanced megakaryocyte numbers and ploidy. The SH2 domain of Lnk is essential for its inhibitory function.","method":"Lnk overexpression and knockout mouse studies, western blot for signaling pathway activation, megakaryocyte culture assays, domain mutagenesis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including KO mice, overexpression, and domain mutagenesis; Moderate-Strong evidence","pmids":["15337790"],"is_preprint":false},{"year":2001,"finding":"Upon TPO stimulation, adaptor proteins Gab1 and Gab2 are tyrosine phosphorylated and associate with Shc, SHP2, PI3-kinase, and Grb2; Gab proteins are the principal PI3-kinase-associated proteins after TPO stimulation. Tyrosine residue Y112 in the C-terminal cytoplasmic domain of c-Mpl is required for Gab1/2 phosphorylation and subsequent PI3-kinase/Akt pathway activation, which is required for TPO-induced cell proliferation.","method":"Co-immunoprecipitation, c-Mpl Y112 mutant expression in UT7 cells and Ba/F3 cells, PI3-kinase activity assays, proliferation assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus site-directed mutagenesis of receptor with functional readout","pmids":["11402314"],"is_preprint":false},{"year":2003,"finding":"TPO stimulates Hoxb4 expression via p38 MAPK, which induces the transcription factor USF-1; this molecular pathway provides a mechanism by which TPO promotes hematopoietic stem cell self-renewal and expansion.","method":"Gene expression analysis in EML and UT-7/TPO cells, tpo-/- mouse comparison, p38 inhibition studies, USF-1 induction assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — KD/inhibitor with defined pathway and HSC phenotype in vivo, single lab","pmids":["12855555"],"is_preprint":false},{"year":2006,"finding":"TPO-induced megakaryocyte polyploidization requires the PI3K-AKT-mTOR-p70S6K pathway; inhibition of MEK increases ploidy while inhibition of mTOR strongly inhibits polyploidization. Cyclin D3 nuclear localization correlates with MEK inhibition-induced polyploidy.","method":"Pharmacological inhibition (PD98059 for MEK, rapamycin for mTOR) in CD34+ cell-derived megakaryocyte cultures, western blot for pathway activation, DNA content analysis","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with defined cellular readout, single lab","pmids":["16449323"],"is_preprint":false},{"year":2007,"finding":"A small nonpeptidyl TPO receptor agonist (SB394725) interacts specifically with His-499 in the transmembrane domain and residues in the extracellular juxtamembrane region (JMR) of c-Mpl; the JMR-TM region consists of two alpha-helices separated by non-helical residues, revealing a distinct mechanism of cytokine receptor activation by small molecules.","method":"NMR structural studies (solution and solid-state), receptor domain swap, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with mutagenesis validation identifying specific interacting residues","pmids":["17369254"],"is_preprint":false},{"year":2011,"finding":"Tensin2 interacts with c-Mpl at phospho-Tyrosine631 and becomes phosphorylated in a TPO-dependent manner; knockdown of Tensin2 dramatically reduces TPO-dependent cell proliferation and Akt signaling, identifying Tensin2 as a novel mediator in the TPO/c-Mpl pathway.","method":"Peptide microarray (SH2/PTB domains), co-precipitation with pY631 peptide, siRNA knockdown, proliferation and Akt phosphorylation assays","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 — microarray discovery confirmed by co-precipitation and functional knockdown, single lab","pmids":["21527831"],"is_preprint":false},{"year":2014,"finding":"JAK2 and MPL protein expression levels determine whether TPO signaling drives megakaryocyte proliferation or differentiation; decreased JAK2 or MPL expression or JAK2 inhibition suppresses the antiproliferative action of TPO, and low-dose JAK2 inhibitors paradoxically increase megakaryocyte production in vitro and in vivo.","method":"shRNA knockdown of JAK2/MPL in UT7-MPL cells, JAK2 chemical inhibitors, analysis of patient samples, in vivo mouse studies","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with defined proliferation/differentiation phenotype, supported by patient data and in vivo confirmation","pmids":["25143485"],"is_preprint":false},{"year":1998,"finding":"TPO stimulation of TF-1/TPO cells induces tyrosine phosphorylation of the common beta subunit (βc) of GM-CSF/IL-3 receptor and its association with Stat5 (but not Shc), demonstrating cross-talk between c-Mpl and GM-CSF/IL-3 receptor signaling pathways.","method":"Immunoprecipitation, western blot for tyrosine phosphorylation, co-precipitation of Stat5 and Shc in TF-1/TPO cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP/pulldown experiment with multiple signaling readouts, single lab","pmids":["9600081"],"is_preprint":false},{"year":2000,"finding":"Platelets store and release biologically active full-length TPO upon activation with platelet agonists; platelet fractionation indicates TPO is contained in granules. In vivo, platelet activation in DIC patients correlates with elevated plasma TPO, suggesting platelets function as a releasable storage pool for TPO.","method":"Platelet activation assays, platelet fractionation, ELISA for TPO in patient samples","journal":"Thrombosis and haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 — direct fractionation experiment with functional TPO release assay and in vivo patient correlation","pmids":["10896250"],"is_preprint":false},{"year":1996,"finding":"TPO activates JAK2 tyrosine kinase and STAT5-related protein tyrosine phosphorylation in the UT-7/TPO megakaryocytic cell line, and drives megakaryocytic maturation including increased ploidy and platelet factor-4 expression.","method":"Western blot for JAK2 and STAT5 tyrosine phosphorylation, RT-PCR for lineage markers in UT-7/TPO cells","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical assays establishing JAK2/STAT5 as TPO effectors in human megakaryocytic cells","pmids":["8639823"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structures of human TPO (thyroid peroxidase) show it as a monomer with four domains (N-terminal, peroxidase domain, CCP-like domain, EGF-like domain); a disulfide bond between Cys146 (POD) and Cys756 (CCP) fixes domain positions. The haem group, active site entrance, and calcium binding site are visible on the opposite side from autoantibody binding epitopes on the POD domain.","method":"Cryo-electron microscopy of purified hTPO in complex with Fab antibodies at 3.4–3.92 Å resolution","journal":"Journal of molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure with domain assignment and identification of catalytic and binding sites","pmids":["36537574"],"is_preprint":false},{"year":1998,"finding":"The proximal histidine (His494) and distal histidine (His239) of thyroid peroxidase (TPO) are essential for catalytic activity; Asn579 in the alternatively spliced region likely forms a stabilizing hydrogen bond with the proximal histidine, explaining the lack of enzymatic activity of the TPO-2 splice variant. Arg396 is conserved across peroxidases and likely participates in compound I formation.","method":"Amino acid sequence alignment with myeloperoxidase, comparative analysis of TPO vs TPO-2 splice variant, multi-species peroxidase alignment","journal":"Thyroid","confidence":"Low","confidence_rationale":"Tier 4 — primarily computational/sequence-based inference without direct mutagenesis in this study","pmids":["9510129"],"is_preprint":false},{"year":2018,"finding":"Triclosan activates the p38 MAPK pathway in thyroid cells, which induces TRHr expression; this p38/TRHr axis then suppresses TPO (thyroid peroxidase) expression and activity, contributing to hypothyroidism.","method":"Rat in vivo triclosan exposure, cell treatment with p38 inhibitors and TRHr siRNA, western blot, RT-PCR in Nthy-ori 3-1 cells","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA knockdown and pharmacological inhibition place TPO downstream of p38/TRHr, two orthogonal methods","pmids":["29462796"],"is_preprint":false},{"year":2020,"finding":"TPO (thrombopoietin) and its receptor c-Mpl are expressed in human CNS neurons; TPO exerts neuroprotective effects in hypoxic-ischemic neonatal rat brain models by promoting cell proliferation via PI3K/Akt signaling and inhibiting apoptosis via the Bcl-2/BAX pathway.","method":"Immunostaining of human CNS tissue, neonatal rat HI brain model, C17.2 cell proliferation assays, western blot for PI3K/Akt and Bcl-2/BAX pathway components","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization plus functional pathway assays in relevant model, single lab","pmids":["32341206"],"is_preprint":false},{"year":2013,"finding":"IL-17A requires functional TPO/c-MPL signaling to exert its effects on granulopoiesis and megakaryopoiesis; in c-mpl-/- mice, IL-17A fails to expand megakaryocytes in bone marrow and does not cause peripheral neutrophil expansion, establishing TPO/c-mpl as required for IL-17A-induced hematopoietic effects.","method":"Genetic epistasis using c-mpl-/- mice with in vivo IL-17A expression, bone marrow and spleen colony-forming assays, cytokine measurements","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic epistasis in KO mice with defined hematopoietic phenotype","pmids":["23990627"],"is_preprint":false},{"year":2003,"finding":"Raf-1 is dispensable for TPO-induced ERK1/2 phosphorylation in megakaryocytes and is not required for megakaryocytopoiesis; raf-1-/- megakaryocytes show normal TPO-induced ERK1/2 activation without compensatory upregulation of A-Raf or B-Raf, indicating other Raf family members mediate ERK activation downstream of TPO.","method":"raf-1-/- knockout mouse megakaryocyte analysis, TPO stimulation assays, western blot for ERK phosphorylation and Raf isoforms, ploidy analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with multiple orthogonal readouts definitively excluding Raf-1 from TPO-ERK pathway","pmids":["14576068"],"is_preprint":false},{"year":2020,"finding":"In vitro enzyme activity assays of TPO (thyroid peroxidase) missense mutations show that residual TPO enzymatic activity correlates with clinical severity: patients with <15% residual activity show severe congenital hypothyroidism, while those with >16% show mild phenotypes.","method":"In vitro TPO enzyme activity assays of mutant constructs, genotype-phenotype correlation in 230 Chinese CH patients","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro enzyme assay with multiple mutants and clinical correlation, single lab","pmids":["32088313"],"is_preprint":false},{"year":2003,"finding":"Iodination of proteins by thyroid peroxidase (TPO) in thyroid cancer cells is strictly dependent on TPO enzymatic activity and independent of NIS (sodium-iodide symporter) function; co-expression of TPO and NIS shows organification requires TPO but not iodide uptake via NIS.","method":"Stable transfection of TPO and NIS constructs, 125I organification assays, specific inhibitors of TPO and NIS","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 1 — direct enzyme assay with specific inhibitors establishing TPO as the organification catalyst independent of NIS","pmids":["15062578"],"is_preprint":false},{"year":2017,"finding":"Lnk deficiency leads to increased TPO signaling and increased osteoclastogenesis; Lnk is expressed in osteoclast lineage cells and Lnk-/- osteoclast progenitors cultured with TPO produce significantly more osteoclasts than WT, establishing a direct role of TPO/c-Mpl/Lnk signaling in bone remodeling.","method":"Lnk-/- mouse bone phenotype analysis (microCT, histomorphometry), in vitro osteoclast differentiation with TPO, alkaline phosphatase assays in osteoblasts","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with defined bone phenotype plus direct in vitro osteoclastogenesis assay, single lab","pmids":["28067429"],"is_preprint":false},{"year":2018,"finding":"TPO (thyroid peroxidase) expressed in breast tissue has enzymatic activity and isoelectric point comparable to thyroid TPO, but with decreased glycosylation and slightly lower molecular weight. In mammary cell lines, TPO is mainly cytoplasmic with insufficient cell-surface expression to detect enzymatic activity, and no dimer formation occurs.","method":"Western blot, enzymatic activity assays, isoelectric focusing, immunohistochemistry, panel of TPO-specific antibodies in breast tissue and cell lines","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical methods characterizing TPO biochemistry in non-thyroid context, single lab","pmids":["29513734"],"is_preprint":false},{"year":2015,"finding":"During megakaryocytic differentiation of UT-7/TPO cells, TPO induces upregulation of PDGFR-α and PDGFR-β and promotes formation of PDGFRαβ heterodimer complexes and complexes between PDGFRs and neuropilin-1 (NRP-1), suggesting NRP-1 participates in megakaryopoiesis through PDGFR interactions.","method":"Co-immunoprecipitation, western blot, immunocytochemistry in UT-7/TPO cells stimulated with TPO and PMA","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP study identifying complex formation, single lab, no functional rescue","pmids":["25744030"],"is_preprint":false}],"current_model":"Thrombopoietin (TPO) binds its receptor c-Mpl to activate JAK2, which phosphorylates receptor tyrosines recruiting STAT3/STAT5, Gab1/2-PI3K-Akt, and Ras-MAPK signaling cascades; the adaptor Lnk negatively regulates this pathway via its SH2 domain; TPO protein levels and JAK2/MPL expression levels together determine whether downstream signaling drives megakaryocyte proliferation versus differentiation, while thyroid peroxidase (TPO) is a heme-containing enzyme whose cryo-EM structure reveals a four-domain monomer with a disulfide-fixed architecture, and whose catalytic histidines (His239/His494) and organification activity are essential for thyroid hormone biosynthesis."},"narrative":{"teleology":[{"year":1995,"claim":"Identification of JAK2–STAT5/STAT3 and Ras pathway activation downstream of TPO/c-Mpl established the core signaling framework through which thrombopoietin controls megakaryocyte biology.","evidence":"Immunoprecipitation and phosphorylation assays in hematopoietic cell lines showing TPO-induced phosphorylation of JAK2, STAT5, STAT3, Shc, Sos, Vav, and c-Cbl","pmids":["7544303","7488109"],"confidence":"High","gaps":["Relative contribution of each downstream pathway to proliferation vs. differentiation was not resolved","Identity of direct JAK2 substrates on c-Mpl cytoplasmic tail not mapped"]},{"year":1998,"claim":"TPO and c-mpl knockout mice demonstrated that TPO is the dominant non-redundant regulator of megakaryopoiesis and platelet production, and that circulating TPO is homeostatically regulated by platelet mass through receptor-mediated uptake.","evidence":"Genetic knockout mice showing 90% platelet reduction, reduced progenitors, decreased megakaryocyte ploidy, and inverse relationship between platelet mass and TPO levels","pmids":["9474742"],"confidence":"High","gaps":["Relative contributions of hepatic production vs. other tissue sources of TPO not fully dissected","Whether residual 10% platelet production depends on alternative cytokines was unclear"]},{"year":1998,"claim":"Sequence-based analysis of thyroid peroxidase identified the catalytic proximal (His494) and distal (His239) histidines and predicted why the TPO-2 splice variant lacking Asn579 is enzymatically inactive.","evidence":"Sequence alignment of TPO with myeloperoxidase and multi-species peroxidases, comparative analysis of TPO vs. TPO-2 splice variant","pmids":["9510129"],"confidence":"Low","gaps":["No direct mutagenesis was performed in this study to validate the histidine assignments","Structural basis remained computational inference without experimental structure"]},{"year":2001,"claim":"Mapping of Gab1/2 recruitment to c-Mpl phospho-Y112 and its requirement for PI3K/Akt activation resolved how TPO couples to the pro-proliferative PI3K pathway through a specific receptor tyrosine.","evidence":"Co-immunoprecipitation and Y112 site-directed mutagenesis in UT7 and Ba/F3 cells with PI3K activity and proliferation assays","pmids":["11402314"],"confidence":"High","gaps":["Whether other receptor tyrosines contribute to PI3K activation was not excluded","Structural basis for Gab1/2 recognition of pY112 not determined"]},{"year":2003,"claim":"TPO was linked to hematopoietic stem cell self-renewal through p38 MAPK–USF-1–Hoxb4 induction, extending TPO function beyond megakaryopoiesis to multipotent progenitor maintenance.","evidence":"Gene expression analysis in EML and UT-7/TPO cells, tpo−/− mouse comparison, p38 inhibition and USF-1 induction assays","pmids":["12855555"],"confidence":"Medium","gaps":["Whether Hoxb4 induction is the sole mediator of TPO-driven HSC expansion was untested","Single laboratory finding"]},{"year":2003,"claim":"Thyroid peroxidase was confirmed as the obligate catalyst for iodide organification, functioning independently of the sodium-iodide symporter NIS.","evidence":"Stable transfection of TPO and NIS constructs with 125I organification assays and specific inhibitors in thyroid cancer cells","pmids":["15062578"],"confidence":"Medium","gaps":["Only tested in cancer cell line context, not primary thyrocytes","Coupling between NIS-mediated iodide transport and TPO at the apical membrane not mechanistically resolved"]},{"year":2004,"claim":"Identification of Lnk as a negative regulator of TPO/c-Mpl signaling, acting through its SH2 domain to attenuate STAT3, STAT5, Akt, and MAPK pathways, revealed a key feedback control node in megakaryopoiesis.","evidence":"Lnk overexpression and knockout mice, western blot, megakaryocyte culture, domain mutagenesis","pmids":["15337790"],"confidence":"High","gaps":["Direct binding partner of Lnk SH2 domain on c-Mpl or JAK2 not mapped","Lnk regulation of other cytokine receptors not distinguished from TPO-specific effects"]},{"year":2006,"claim":"Dissection of PI3K–Akt–mTOR versus MEK–ERK pathways showed that mTOR is required for TPO-induced polyploidization while MEK opposes it, clarifying how a single cytokine directs both proliferation and endomitotic differentiation.","evidence":"Pharmacological inhibition (rapamycin, PD98059) in CD34+ cell-derived megakaryocyte cultures with ploidy analysis","pmids":["16449323"],"confidence":"Medium","gaps":["Pharmacological inhibitors lack complete specificity","Direct mTOR substrates mediating polyploidization not identified"]},{"year":2007,"claim":"NMR structural characterization of the c-Mpl transmembrane and juxtamembrane region in complex with a small-molecule agonist revealed a two-helix architecture and identified His-499 as a critical contact, providing a structural basis for non-peptide TPO mimetics.","evidence":"Solution and solid-state NMR, domain swap and site-directed mutagenesis of c-Mpl","pmids":["17369254"],"confidence":"High","gaps":["Full-length receptor structure with native TPO ligand not determined","Whether the small-molecule activation mechanism fully mimics TPO-induced conformational change was unclear"]},{"year":2014,"claim":"Demonstration that JAK2 and MPL expression levels gate the proliferation-versus-differentiation decision resolved the paradox of how graded TPO signaling generates distinct megakaryocyte fates.","evidence":"shRNA knockdown of JAK2/MPL, JAK2 chemical inhibitors in UT7-MPL cells, patient sample analysis, in vivo mouse studies","pmids":["25143485"],"confidence":"Medium","gaps":["Quantitative thresholds for the switch not precisely defined","Whether this applies to HSC compartment or only committed megakaryocyte progenitors unclear"]},{"year":2020,"claim":"Genotype-phenotype correlation for thyroid peroxidase missense mutations established that residual enzymatic activity below ~15% causes severe congenital hypothyroidism, directly linking TPO catalytic function to disease severity.","evidence":"In vitro TPO enzyme activity assays of mutant constructs correlated with clinical phenotypes in 230 Chinese congenital hypothyroidism patients","pmids":["32088313"],"confidence":"Medium","gaps":["Activity measurements in vitro may not fully reflect in vivo folding and trafficking","Cohort from single ethnic background"]},{"year":2023,"claim":"Cryo-EM structures of human thyroid peroxidase resolved its four-domain architecture, heme environment, and autoantibody epitope locations, providing the first near-atomic model of this enzyme.","evidence":"Cryo-EM of purified hTPO–Fab complexes at 3.4–3.92 Å resolution","pmids":["36537574"],"confidence":"High","gaps":["Structure of TPO in complex with thyroglobulin substrate not determined","Catalytic mechanism of iodination not captured at atomic detail in transition-state analogs"]},{"year":null,"claim":"The structural basis for TPO (thrombopoietin) binding to full-length c-Mpl and the conformational changes that discriminate proliferative from differentiative signaling remain unresolved; for thyroid peroxidase, the mechanism of substrate (thyroglobulin) recognition and coupling reaction at the apical membrane has not been structurally characterized.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length TPO–c-Mpl complex structure exists","Structural basis for thyroglobulin coupling by thyroid peroxidase is unknown","How TPO signaling strength is quantitatively decoded into distinct transcriptional programs is mechanistically unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[13,14,19,20,22]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,2,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,21]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2,11]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[13,20,22]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,4,6,8,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,17]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[2,11]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[13,19,20]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,6,9]}],"complexes":[],"partners":["MPL","JAK2","STAT5","STAT3","LNK","GAB1","GAB2","TNS2"],"other_free_text":[]},"mechanistic_narrative":"The gene symbol TPO maps to two distinct genes: thrombopoietin (THPO) and thyroid peroxidase (TPO). Thrombopoietin is the primary cytokine regulating megakaryopoiesis and platelet production; it binds the c-Mpl receptor to activate JAK2, which phosphorylates STAT3/STAT5 and recruits Gab1/2–PI3K–Akt and Ras–MAPK cascades, with the adaptor Lnk acting as a negative regulator through its SH2 domain, and circulating TPO levels are homeostatically controlled by platelet mass via c-Mpl-mediated uptake [PMID:7544303, PMID:9474742, PMID:15337790, PMID:11402314]. The relative expression levels of JAK2 and MPL determine whether TPO signaling drives megakaryocyte proliferation or differentiation, and TPO additionally promotes hematopoietic stem cell self-renewal through p38 MAPK–USF-1–Hoxb4 induction [PMID:25143485, PMID:12855555]. Thyroid peroxidase is a heme-containing enzyme essential for thyroid hormone biosynthesis that catalyzes iodide organification independently of NIS; its cryo-EM structure reveals a four-domain monomer with catalytic histidines His239 and His494, and loss-of-function mutations causing residual activity below ~15% result in severe congenital hypothyroidism [PMID:36537574, PMID:15062578, PMID:32088313]."},"prefetch_data":{"uniprot":{"accession":"P07202","full_name":"Thyroid peroxidase","aliases":[],"length_aa":933,"mass_kda":103.0,"function":"Iodination and coupling of the hormonogenic tyrosines in thyroglobulin to yield the thyroid hormones T(3) and T(4)","subcellular_location":"Cell surface","url":"https://www.uniprot.org/uniprotkb/P07202/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TPO","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TPO","total_profiled":1310},"omim":[{"mim_id":"621096","title":"IMMUNODEFICIENCY 132B; IMD132B","url":"https://www.omim.org/entry/621096"},{"mim_id":"620931","title":"IMMUNODEFICIENCY 126, SUSCEPTIBILITY TO; IMD126","url":"https://www.omim.org/entry/620931"},{"mim_id":"619855","title":"THYROID HORMONE METABOLISM, ABNORMAL, 2; THMA2","url":"https://www.omim.org/entry/619855"},{"mim_id":"619220","title":"IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78","url":"https://www.omim.org/entry/619220"},{"mim_id":"617792","title":"THIOREDOXIN DOMAIN-CONTAINING PROTEIN 11; TXNDC11","url":"https://www.omim.org/entry/617792"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"thyroid gland","ntpm":1387.6}],"url":"https://www.proteinatlas.org/search/TPO"},"hgnc":{"alias_symbol":["TPX"],"prev_symbol":[]},"alphafold":{"accession":"P07202","domains":[{"cath_id":"-","chopping":"36-201","consensus_level":"medium","plddt":82.7098,"start":36,"end":201},{"cath_id":"2.10.70.10","chopping":"736-797","consensus_level":"medium","plddt":86.6168,"start":736,"end":797},{"cath_id":"2.10.25.10","chopping":"801-841","consensus_level":"medium","plddt":83.3539,"start":801,"end":841},{"cath_id":"1.20.5","chopping":"2-32","consensus_level":"medium","plddt":54.7145,"start":2,"end":32}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P07202","model_url":"https://alphafold.ebi.ac.uk/files/AF-P07202-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P07202-F1-predicted_aligned_error_v6.png","plddt_mean":83.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TPO","jax_strain_url":"https://www.jax.org/strain/search?query=TPO"},"sequence":{"accession":"P07202","fasta_url":"https://rest.uniprot.org/uniprotkb/P07202.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P07202/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P07202"}},"corpus_meta":[{"pmid":"30093503","id":"PMC_30093503","title":"Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.","date":"2018","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/30093503","citation_count":398,"is_preprint":false},{"pmid":"15337790","id":"PMC_15337790","title":"Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15337790","citation_count":160,"is_preprint":false},{"pmid":"8639823","id":"PMC_8639823","title":"Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8639823","citation_count":99,"is_preprint":false},{"pmid":"9888818","id":"PMC_9888818","title":"Purification and characterization of a second type thioredoxin peroxidase (type II TPx) from Saccharomyces cerevisiae.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9888818","citation_count":97,"is_preprint":false},{"pmid":"9474742","id":"PMC_9474742","title":"Hematopoietic deficiencies in c-mpl and TPO knockout mice.","date":"1998","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/9474742","citation_count":90,"is_preprint":false},{"pmid":"20153806","id":"PMC_20153806","title":"Genetics and phenomics of hypothyroidism and goiter due to TPO mutations.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20153806","citation_count":88,"is_preprint":false},{"pmid":"7498368","id":"PMC_7498368","title":"Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines.","date":"1995","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/7498368","citation_count":86,"is_preprint":false},{"pmid":"12855555","id":"PMC_12855555","title":"Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12855555","citation_count":83,"is_preprint":false},{"pmid":"34160821","id":"PMC_34160821","title":"Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists.","date":"2021","source":"Drugs","url":"https://pubmed.ncbi.nlm.nih.gov/34160821","citation_count":79,"is_preprint":false},{"pmid":"7544303","id":"PMC_7544303","title":"Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7544303","citation_count":77,"is_preprint":false},{"pmid":"34158340","id":"PMC_34158340","title":"TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations.","date":"2021","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/34158340","citation_count":75,"is_preprint":false},{"pmid":"18515414","id":"PMC_18515414","title":"The Campylobacter jejuni thiol peroxidases Tpx and Bcp both contribute to aerotolerance and peroxide-mediated stress resistance but have distinct substrate specificities.","date":"2008","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/18515414","citation_count":70,"is_preprint":false},{"pmid":"11144214","id":"PMC_11144214","title":"Tpx-1 is a component of the outer dense fibers and acrosome of rat spermatozoa.","date":"2001","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/11144214","citation_count":69,"is_preprint":false},{"pmid":"30479075","id":"PMC_30479075","title":"Causal Relationship Between Anti-TPO IgE and Chronic Urticaria by In Vitro and In Vivo Tests.","date":"2019","source":"Allergy, asthma & immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/30479075","citation_count":68,"is_preprint":false},{"pmid":"10896250","id":"PMC_10896250","title":"Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?","date":"2000","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/10896250","citation_count":66,"is_preprint":false},{"pmid":"16060913","id":"PMC_16060913","title":"Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis.","date":"2005","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16060913","citation_count":65,"is_preprint":false},{"pmid":"9675100","id":"PMC_9675100","title":"Molecular cloning of the rat Tpx-1 responsible for the interaction between spermatogenic and Sertoli cells.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9675100","citation_count":62,"is_preprint":false},{"pmid":"28648508","id":"PMC_28648508","title":"Iodide handling disorders (NIS, TPO, TG, IYD).","date":"2017","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28648508","citation_count":61,"is_preprint":false},{"pmid":"23913253","id":"PMC_23913253","title":"Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.","date":"2013","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/23913253","citation_count":61,"is_preprint":false},{"pmid":"7488109","id":"PMC_7488109","title":"TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7488109","citation_count":60,"is_preprint":false},{"pmid":"16449323","id":"PMC_16449323","title":"Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16449323","citation_count":55,"is_preprint":false},{"pmid":"17369254","id":"PMC_17369254","title":"NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17369254","citation_count":55,"is_preprint":false},{"pmid":"7544244","id":"PMC_7544244","title":"Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: markers of the human thyroid autoimmune response.","date":"1995","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7544244","citation_count":53,"is_preprint":false},{"pmid":"32883611","id":"PMC_32883611","title":"TPO antibody positivity and adverse pregnancy outcomes.","date":"2020","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32883611","citation_count":52,"is_preprint":false},{"pmid":"25143485","id":"PMC_25143485","title":"JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25143485","citation_count":50,"is_preprint":false},{"pmid":"23236987","id":"PMC_23236987","title":"Thyroid dyshormonogenesis is mainly caused by TPO mutations in consanguineous community.","date":"2013","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23236987","citation_count":50,"is_preprint":false},{"pmid":"24554511","id":"PMC_24554511","title":"Increased TRAb and/or low anti-TPO titers at diagnosis of graves' disease are associated with an increased risk of developing ophthalmopathy after onset.","date":"2014","source":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","url":"https://pubmed.ncbi.nlm.nih.gov/24554511","citation_count":45,"is_preprint":false},{"pmid":"31146647","id":"PMC_31146647","title":"Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).","date":"2019","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/31146647","citation_count":44,"is_preprint":false},{"pmid":"34365220","id":"PMC_34365220","title":"Will the clinical development of 4th-generation \"double mutant active\" ALK TKIs (TPX-0131 and NVL-655) change the future treatment paradigm of ALK+ NSCLC?","date":"2021","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34365220","citation_count":43,"is_preprint":false},{"pmid":"19340292","id":"PMC_19340292","title":"Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpX.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19340292","citation_count":42,"is_preprint":false},{"pmid":"11402314","id":"PMC_11402314","title":"Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo).","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11402314","citation_count":39,"is_preprint":false},{"pmid":"10468986","id":"PMC_10468986","title":"A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect.","date":"1999","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10468986","citation_count":38,"is_preprint":false},{"pmid":"16684826","id":"PMC_16684826","title":"Goitrous congenital hypothyroidism and hearing impairment associated with mutations in the TPO and SLC26A4/PDS genes.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16684826","citation_count":38,"is_preprint":false},{"pmid":"11012188","id":"PMC_11012188","title":"Endogenous TPO (eTPO) levels in health and disease: possible clues for therapeutic intervention.","date":"1998","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/11012188","citation_count":37,"is_preprint":false},{"pmid":"18093840","id":"PMC_18093840","title":"TPO-independent megakaryocytopoiesis.","date":"2008","source":"Critical reviews in oncology/hematology","url":"https://pubmed.ncbi.nlm.nih.gov/18093840","citation_count":36,"is_preprint":false},{"pmid":"7524700","id":"PMC_7524700","title":"Cloning and characterisation of TPO autoantibodies using combinatorial phage display libraries.","date":"1994","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/7524700","citation_count":36,"is_preprint":false},{"pmid":"36893453","id":"PMC_36893453","title":"Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/36893453","citation_count":34,"is_preprint":false},{"pmid":"22681640","id":"PMC_22681640","title":"Immune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder.","date":"2012","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/22681640","citation_count":34,"is_preprint":false},{"pmid":"36965373","id":"PMC_36965373","title":"Ameliorative effects of mangiferin derivative TPX on insulin resistance via PI3K/AKT and AMPK signaling pathways in human HepG2 and HL-7702 hepatocytes.","date":"2023","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36965373","citation_count":33,"is_preprint":false},{"pmid":"29462796","id":"PMC_29462796","title":"P38/TRHr-Dependent Regulation of TPO in Thyroid Cells Contributes to the Hypothyroidism of Triclosan-Treated Rats.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29462796","citation_count":32,"is_preprint":false},{"pmid":"1671388","id":"PMC_1671388","title":"Genetic linkage studies of thyroid peroxidase (TPO) gene in families with TPO deficiency.","date":"1991","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/1671388","citation_count":32,"is_preprint":false},{"pmid":"21853157","id":"PMC_21853157","title":"Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK megakaryoblastic leukemic cell growth by promoting apoptosis.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21853157","citation_count":32,"is_preprint":false},{"pmid":"21707688","id":"PMC_21707688","title":"Molecular screening of the TSH receptor (TSHR) and thyroid peroxidase (TPO) genes in Korean patients with nonsyndromic congenital hypothyroidism.","date":"2011","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21707688","citation_count":30,"is_preprint":false},{"pmid":"16478776","id":"PMC_16478776","title":"Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-1alpha/IFN-gamma, an effect partially mediated by nitric oxide.","date":"2006","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16478776","citation_count":29,"is_preprint":false},{"pmid":"27329729","id":"PMC_27329729","title":"Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27329729","citation_count":29,"is_preprint":false},{"pmid":"28544774","id":"PMC_28544774","title":"Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals.","date":"2017","source":"Basic & clinical pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28544774","citation_count":29,"is_preprint":false},{"pmid":"21476857","id":"PMC_21476857","title":"A TPO receptor agonist, ALXN4100TPO, mitigates radiation-induced lethality and stimulates hematopoiesis in CD2F1 mice.","date":"2011","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/21476857","citation_count":28,"is_preprint":false},{"pmid":"16597467","id":"PMC_16597467","title":"2-Cys Peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei.","date":"2006","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16597467","citation_count":27,"is_preprint":false},{"pmid":"10323395","id":"PMC_10323395","title":"Cellular thyroid peroxidase (TPO), unlike purified TPO and adjuvant, induces antibodies in mice that resemble autoantibodies in human autoimmune thyroid disease.","date":"1999","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10323395","citation_count":26,"is_preprint":false},{"pmid":"17381485","id":"PMC_17381485","title":"Clinical and genetic characteristics of congenital hypothyroidism due to mutations in the thyroid peroxidase (TPO) gene in Israelis.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17381485","citation_count":26,"is_preprint":false},{"pmid":"10606962","id":"PMC_10606962","title":"Evidence for antigen presentation to sensitized T cells by thyroid peroxidase (TPO)-specific B cells in mice injected with fibroblasts co-expressing TPO and MHC class II.","date":"2000","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10606962","citation_count":26,"is_preprint":false},{"pmid":"7607688","id":"PMC_7607688","title":"Localization of TDPX1, a human homologue of the yeast thioredoxin-dependent peroxide reductase gene (TPX), to chromosome 13q12.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7607688","citation_count":25,"is_preprint":false},{"pmid":"21527831","id":"PMC_21527831","title":"Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling.","date":"2011","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21527831","citation_count":24,"is_preprint":false},{"pmid":"31867598","id":"PMC_31867598","title":"Increased Prevalence of TG and TPO Mutations in Sudanese Children With Congenital Hypothyroidism.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31867598","citation_count":23,"is_preprint":false},{"pmid":"15966759","id":"PMC_15966759","title":"Mesenchymal stem cells support expansion of in vitro irradiated CD34(+) cells in the presence of SCF, FLT3 ligand, TPO and IL3: potential application to autologous cell therapy in accidentally irradiated victims.","date":"2005","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/15966759","citation_count":23,"is_preprint":false},{"pmid":"32798586","id":"PMC_32798586","title":"Effects of butylparaben exposure on thyroid peroxidase (TPO) and type 1 iodothyronine deiodinase (D1) in female Wistar rats.","date":"2020","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/32798586","citation_count":23,"is_preprint":false},{"pmid":"10784074","id":"PMC_10784074","title":"Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors.","date":"2000","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/10784074","citation_count":23,"is_preprint":false},{"pmid":"32980989","id":"PMC_32980989","title":"Thyroid peroxidase in human endometrium and placenta: a potential target for anti-TPO antibodies.","date":"2020","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32980989","citation_count":22,"is_preprint":false},{"pmid":"24085601","id":"PMC_24085601","title":"The TPO/c-MPL pathway in the bone marrow may protect leukemia cells from chemotherapy in AML Patients.","date":"2013","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/24085601","citation_count":22,"is_preprint":false},{"pmid":"26064355","id":"PMC_26064355","title":"Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26064355","citation_count":21,"is_preprint":false},{"pmid":"14576068","id":"PMC_14576068","title":"Raf-1 is not required for megakaryocytopoiesis or TPO-induced ERK phosphorylation.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/14576068","citation_count":21,"is_preprint":false},{"pmid":"31852910","id":"PMC_31852910","title":"Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31852910","citation_count":21,"is_preprint":false},{"pmid":"28456746","id":"PMC_28456746","title":"Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.","date":"2017","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/28456746","citation_count":21,"is_preprint":false},{"pmid":"17971220","id":"PMC_17971220","title":"Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO.","date":"2007","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17971220","citation_count":21,"is_preprint":false},{"pmid":"32088313","id":"PMC_32088313","title":"The TPO mutation screening and genotype-phenotype analysis in 230 Chinese patients with congenital hypothyroidism.","date":"2020","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32088313","citation_count":20,"is_preprint":false},{"pmid":"27173810","id":"PMC_27173810","title":"Mutation screening of the TPO gene in a cohort of 192 Chinese patients with congenital hypothyroidism.","date":"2016","source":"BMJ open","url":"https://pubmed.ncbi.nlm.nih.gov/27173810","citation_count":20,"is_preprint":false},{"pmid":"28142109","id":"PMC_28142109","title":"Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia.","date":"2017","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/28142109","citation_count":20,"is_preprint":false},{"pmid":"23754668","id":"PMC_23754668","title":"TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.","date":"2013","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23754668","citation_count":20,"is_preprint":false},{"pmid":"29513734","id":"PMC_29513734","title":"Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29513734","citation_count":18,"is_preprint":false},{"pmid":"28575127","id":"PMC_28575127","title":"Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28575127","citation_count":18,"is_preprint":false},{"pmid":"29296963","id":"PMC_29296963","title":"Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells.","date":"2017","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/29296963","citation_count":18,"is_preprint":false},{"pmid":"24420335","id":"PMC_24420335","title":"Genetic analysis of thyroid peroxidase (TPO) gene in patients whose hypothyroidism was found in adulthood in West Bengal, India.","date":"2014","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/24420335","citation_count":18,"is_preprint":false},{"pmid":"11593644","id":"PMC_11593644","title":"Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha.","date":"1999","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11593644","citation_count":17,"is_preprint":false},{"pmid":"10960526","id":"PMC_10960526","title":"Thrombopoietin and the TPO receptorduring platelet storage.","date":"2000","source":"Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/10960526","citation_count":17,"is_preprint":false},{"pmid":"15753672","id":"PMC_15753672","title":"Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.","date":"2005","source":"Thyroid : official journal of the American Thyroid Association","url":"https://pubmed.ncbi.nlm.nih.gov/15753672","citation_count":17,"is_preprint":false},{"pmid":"9600081","id":"PMC_9600081","title":"Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9600081","citation_count":16,"is_preprint":false},{"pmid":"35612671","id":"PMC_35612671","title":"The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046.","date":"2022","source":"Investigational new drugs","url":"https://pubmed.ncbi.nlm.nih.gov/35612671","citation_count":15,"is_preprint":false},{"pmid":"30160475","id":"PMC_30160475","title":"GLI1 Inhibitors Identified by Target Protein Oriented Natural Products Isolation (TPO-NAPI) with Hedgehog Inhibition.","date":"2018","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/30160475","citation_count":15,"is_preprint":false},{"pmid":"9574554","id":"PMC_9574554","title":"Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9574554","citation_count":14,"is_preprint":false},{"pmid":"16649969","id":"PMC_16649969","title":"Congenital primary hypothyroidism with subsequent adenomatous goiter in a Turkish patient caused by a homozygous 10-bp deletion in the thyroid peroxidase (TPO) gene.","date":"2006","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16649969","citation_count":14,"is_preprint":false},{"pmid":"29212120","id":"PMC_29212120","title":"Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.","date":"2017","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/29212120","citation_count":14,"is_preprint":false},{"pmid":"27797414","id":"PMC_27797414","title":"TPO-RAs in pITP: description of a case series and analysis of predictive factors for response.","date":"2016","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/27797414","citation_count":14,"is_preprint":false},{"pmid":"23865082","id":"PMC_23865082","title":"Is there a link between Hashimoto's thyroiditis and primary hyperparathyroidism? A study of serum parathormone and anti-TPO antibodies in 2267 patients.","date":"2013","source":"Hellenic journal of nuclear medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23865082","citation_count":14,"is_preprint":false},{"pmid":"27829681","id":"PMC_27829681","title":"Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27829681","citation_count":14,"is_preprint":false},{"pmid":"32341206","id":"PMC_32341206","title":"c-Mpl and TPO expression in the human central nervous system neurons inhibits neuronal apoptosis.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32341206","citation_count":13,"is_preprint":false},{"pmid":"32078117","id":"PMC_32078117","title":"Mild TPO deficiency characterized by progressive goiter and normal serum TSH level.","date":"2020","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/32078117","citation_count":13,"is_preprint":false},{"pmid":"9510129","id":"PMC_9510129","title":"Proximal and distal histidines in thyroid peroxidase: relation to the alternatively spliced form, TPO-2.","date":"1998","source":"Thyroid : official journal of the American Thyroid Association","url":"https://pubmed.ncbi.nlm.nih.gov/9510129","citation_count":13,"is_preprint":false},{"pmid":"32133382","id":"PMC_32133382","title":"A Novel Thioredoxin-Dependent Peroxiredoxin (TPx-Q) Plays an Important Role in Defense Against Oxidative Stress and Is a Possible Drug Target in Babesia microti.","date":"2020","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/32133382","citation_count":13,"is_preprint":false},{"pmid":"32377237","id":"PMC_32377237","title":"ASSOCIATION OF FOXP3 GENE VARIANTS WITH RISK OF HASHIMOTO'S THYROIDITIS AND CORRELATION WITH ANTI-TPO ANTIBODY LEVELS.","date":"2019","source":"Acta endocrinologica (Bucharest, Romania : 2005)","url":"https://pubmed.ncbi.nlm.nih.gov/32377237","citation_count":13,"is_preprint":false},{"pmid":"9678722","id":"PMC_9678722","title":"Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF, GM-CSF, M-CSF, SCF and TPO.","date":"1998","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/9678722","citation_count":13,"is_preprint":false},{"pmid":"31585887","id":"PMC_31585887","title":"Homology between TSH-R/Tg/TPO and Hashimoto's encephalopathy autoantigens.","date":"2020","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/31585887","citation_count":12,"is_preprint":false},{"pmid":"15062578","id":"PMC_15062578","title":"Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS.","date":"2003","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15062578","citation_count":12,"is_preprint":false},{"pmid":"25241611","id":"PMC_25241611","title":"One Base Deletion (c.2422delT) in the TPO Gene Causes Severe Congenital Hypothyroidism.","date":"2014","source":"Journal of clinical research in pediatric endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25241611","citation_count":12,"is_preprint":false},{"pmid":"36537574","id":"PMC_36537574","title":"Cryo-electron microscopy structures of human thyroid peroxidase (TPO) in complex with TPO antibodies.","date":"2023","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36537574","citation_count":11,"is_preprint":false},{"pmid":"37407700","id":"PMC_37407700","title":"TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37407700","citation_count":11,"is_preprint":false},{"pmid":"37907956","id":"PMC_37907956","title":"The association of Treg and Th17 cells development factors and anti-TPO autoantibodies in patients with recurrent pregnancy loss.","date":"2023","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/37907956","citation_count":11,"is_preprint":false},{"pmid":"28067429","id":"PMC_28067429","title":"Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28067429","citation_count":11,"is_preprint":false},{"pmid":"25744030","id":"PMC_25744030","title":"Platelet-derived growth factor receptors form complexes with neuropilin-1 during megakaryocytic differentiation of thrombopoietin-dependent UT-7/TPO cells.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25744030","citation_count":11,"is_preprint":false},{"pmid":"23990627","id":"PMC_23990627","title":"Requirement of TPO/c-mpl for IL-17A-induced granulopoiesis and megakaryopoiesis.","date":"2013","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/23990627","citation_count":11,"is_preprint":false},{"pmid":"21970435","id":"PMC_21970435","title":"Fibronectin promotes proplatelet formation in the human megakaryocytic cell line UT-7/TPO.","date":"2012","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/21970435","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52946,"output_tokens":5630,"usd":0.121644},"stage2":{"model":"claude-opus-4-6","input_tokens":9216,"output_tokens":3223,"usd":0.189982},"total_usd":0.311626,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"TPO (thrombopoietin) binding to c-Mpl induces tyrosine phosphorylation and activation of STAT5 and STAT3, defining a rapid JAK-STAT signaling pathway downstream of the TPO receptor.\",\n      \"method\": \"Immunoprecipitation, electrophoretic mobility shift assay (EMSA), tyrosine phosphorylation assays in hematopoietic cell lines\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP and functional assays, replicated alongside JAK2 activation findings\",\n      \"pmids\": [\"7544303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"TPO/c-mpl signaling induces tyrosine phosphorylation of JAK2, Shc, Sos (Ras pathway components), Vav, and c-Cbl, indicating activation of both JAK/STAT and Ras signaling pathways downstream of c-Mpl.\",\n      \"method\": \"Tyrosine phosphorylation assays and immunoprecipitation in Mo7e megakaryoblastic cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical assays with multiple substrates identified, consistent with parallel studies\",\n      \"pmids\": [\"7488109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TPO knockout and c-mpl knockout mice show 90% reduction in platelets due to reduced hematopoietic progenitor numbers and decreased megakaryocyte ploidy; circulating TPO levels are regulated by platelet mass through c-Mpl-mediated binding and uptake, establishing a feedback mechanism for TPO homeostasis.\",\n      \"method\": \"Genetic knockout mouse models, bone marrow analysis, platelet counts, repopulation assays\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, replicated in two independent gene-targeted mouse lines\",\n      \"pmids\": [\"9474742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The adaptor protein Lnk negatively regulates TPO/c-Mpl signaling; Lnk overexpression attenuates TPO-induced STAT3, STAT5, Akt, and MAPK activation, and Lnk deficiency results in enhanced megakaryocyte numbers and ploidy. The SH2 domain of Lnk is essential for its inhibitory function.\",\n      \"method\": \"Lnk overexpression and knockout mouse studies, western blot for signaling pathway activation, megakaryocyte culture assays, domain mutagenesis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including KO mice, overexpression, and domain mutagenesis; Moderate-Strong evidence\",\n      \"pmids\": [\"15337790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Upon TPO stimulation, adaptor proteins Gab1 and Gab2 are tyrosine phosphorylated and associate with Shc, SHP2, PI3-kinase, and Grb2; Gab proteins are the principal PI3-kinase-associated proteins after TPO stimulation. Tyrosine residue Y112 in the C-terminal cytoplasmic domain of c-Mpl is required for Gab1/2 phosphorylation and subsequent PI3-kinase/Akt pathway activation, which is required for TPO-induced cell proliferation.\",\n      \"method\": \"Co-immunoprecipitation, c-Mpl Y112 mutant expression in UT7 cells and Ba/F3 cells, PI3-kinase activity assays, proliferation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus site-directed mutagenesis of receptor with functional readout\",\n      \"pmids\": [\"11402314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TPO stimulates Hoxb4 expression via p38 MAPK, which induces the transcription factor USF-1; this molecular pathway provides a mechanism by which TPO promotes hematopoietic stem cell self-renewal and expansion.\",\n      \"method\": \"Gene expression analysis in EML and UT-7/TPO cells, tpo-/- mouse comparison, p38 inhibition studies, USF-1 induction assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD/inhibitor with defined pathway and HSC phenotype in vivo, single lab\",\n      \"pmids\": [\"12855555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TPO-induced megakaryocyte polyploidization requires the PI3K-AKT-mTOR-p70S6K pathway; inhibition of MEK increases ploidy while inhibition of mTOR strongly inhibits polyploidization. Cyclin D3 nuclear localization correlates with MEK inhibition-induced polyploidy.\",\n      \"method\": \"Pharmacological inhibition (PD98059 for MEK, rapamycin for mTOR) in CD34+ cell-derived megakaryocyte cultures, western blot for pathway activation, DNA content analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with defined cellular readout, single lab\",\n      \"pmids\": [\"16449323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A small nonpeptidyl TPO receptor agonist (SB394725) interacts specifically with His-499 in the transmembrane domain and residues in the extracellular juxtamembrane region (JMR) of c-Mpl; the JMR-TM region consists of two alpha-helices separated by non-helical residues, revealing a distinct mechanism of cytokine receptor activation by small molecules.\",\n      \"method\": \"NMR structural studies (solution and solid-state), receptor domain swap, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with mutagenesis validation identifying specific interacting residues\",\n      \"pmids\": [\"17369254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tensin2 interacts with c-Mpl at phospho-Tyrosine631 and becomes phosphorylated in a TPO-dependent manner; knockdown of Tensin2 dramatically reduces TPO-dependent cell proliferation and Akt signaling, identifying Tensin2 as a novel mediator in the TPO/c-Mpl pathway.\",\n      \"method\": \"Peptide microarray (SH2/PTB domains), co-precipitation with pY631 peptide, siRNA knockdown, proliferation and Akt phosphorylation assays\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — microarray discovery confirmed by co-precipitation and functional knockdown, single lab\",\n      \"pmids\": [\"21527831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"JAK2 and MPL protein expression levels determine whether TPO signaling drives megakaryocyte proliferation or differentiation; decreased JAK2 or MPL expression or JAK2 inhibition suppresses the antiproliferative action of TPO, and low-dose JAK2 inhibitors paradoxically increase megakaryocyte production in vitro and in vivo.\",\n      \"method\": \"shRNA knockdown of JAK2/MPL in UT7-MPL cells, JAK2 chemical inhibitors, analysis of patient samples, in vivo mouse studies\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined proliferation/differentiation phenotype, supported by patient data and in vivo confirmation\",\n      \"pmids\": [\"25143485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TPO stimulation of TF-1/TPO cells induces tyrosine phosphorylation of the common beta subunit (βc) of GM-CSF/IL-3 receptor and its association with Stat5 (but not Shc), demonstrating cross-talk between c-Mpl and GM-CSF/IL-3 receptor signaling pathways.\",\n      \"method\": \"Immunoprecipitation, western blot for tyrosine phosphorylation, co-precipitation of Stat5 and Shc in TF-1/TPO cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP/pulldown experiment with multiple signaling readouts, single lab\",\n      \"pmids\": [\"9600081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Platelets store and release biologically active full-length TPO upon activation with platelet agonists; platelet fractionation indicates TPO is contained in granules. In vivo, platelet activation in DIC patients correlates with elevated plasma TPO, suggesting platelets function as a releasable storage pool for TPO.\",\n      \"method\": \"Platelet activation assays, platelet fractionation, ELISA for TPO in patient samples\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation experiment with functional TPO release assay and in vivo patient correlation\",\n      \"pmids\": [\"10896250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TPO activates JAK2 tyrosine kinase and STAT5-related protein tyrosine phosphorylation in the UT-7/TPO megakaryocytic cell line, and drives megakaryocytic maturation including increased ploidy and platelet factor-4 expression.\",\n      \"method\": \"Western blot for JAK2 and STAT5 tyrosine phosphorylation, RT-PCR for lineage markers in UT-7/TPO cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical assays establishing JAK2/STAT5 as TPO effectors in human megakaryocytic cells\",\n      \"pmids\": [\"8639823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structures of human TPO (thyroid peroxidase) show it as a monomer with four domains (N-terminal, peroxidase domain, CCP-like domain, EGF-like domain); a disulfide bond between Cys146 (POD) and Cys756 (CCP) fixes domain positions. The haem group, active site entrance, and calcium binding site are visible on the opposite side from autoantibody binding epitopes on the POD domain.\",\n      \"method\": \"Cryo-electron microscopy of purified hTPO in complex with Fab antibodies at 3.4–3.92 Å resolution\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure with domain assignment and identification of catalytic and binding sites\",\n      \"pmids\": [\"36537574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The proximal histidine (His494) and distal histidine (His239) of thyroid peroxidase (TPO) are essential for catalytic activity; Asn579 in the alternatively spliced region likely forms a stabilizing hydrogen bond with the proximal histidine, explaining the lack of enzymatic activity of the TPO-2 splice variant. Arg396 is conserved across peroxidases and likely participates in compound I formation.\",\n      \"method\": \"Amino acid sequence alignment with myeloperoxidase, comparative analysis of TPO vs TPO-2 splice variant, multi-species peroxidase alignment\",\n      \"journal\": \"Thyroid\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — primarily computational/sequence-based inference without direct mutagenesis in this study\",\n      \"pmids\": [\"9510129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Triclosan activates the p38 MAPK pathway in thyroid cells, which induces TRHr expression; this p38/TRHr axis then suppresses TPO (thyroid peroxidase) expression and activity, contributing to hypothyroidism.\",\n      \"method\": \"Rat in vivo triclosan exposure, cell treatment with p38 inhibitors and TRHr siRNA, western blot, RT-PCR in Nthy-ori 3-1 cells\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown and pharmacological inhibition place TPO downstream of p38/TRHr, two orthogonal methods\",\n      \"pmids\": [\"29462796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TPO (thrombopoietin) and its receptor c-Mpl are expressed in human CNS neurons; TPO exerts neuroprotective effects in hypoxic-ischemic neonatal rat brain models by promoting cell proliferation via PI3K/Akt signaling and inhibiting apoptosis via the Bcl-2/BAX pathway.\",\n      \"method\": \"Immunostaining of human CNS tissue, neonatal rat HI brain model, C17.2 cell proliferation assays, western blot for PI3K/Akt and Bcl-2/BAX pathway components\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization plus functional pathway assays in relevant model, single lab\",\n      \"pmids\": [\"32341206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IL-17A requires functional TPO/c-MPL signaling to exert its effects on granulopoiesis and megakaryopoiesis; in c-mpl-/- mice, IL-17A fails to expand megakaryocytes in bone marrow and does not cause peripheral neutrophil expansion, establishing TPO/c-mpl as required for IL-17A-induced hematopoietic effects.\",\n      \"method\": \"Genetic epistasis using c-mpl-/- mice with in vivo IL-17A expression, bone marrow and spleen colony-forming assays, cytokine measurements\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic epistasis in KO mice with defined hematopoietic phenotype\",\n      \"pmids\": [\"23990627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Raf-1 is dispensable for TPO-induced ERK1/2 phosphorylation in megakaryocytes and is not required for megakaryocytopoiesis; raf-1-/- megakaryocytes show normal TPO-induced ERK1/2 activation without compensatory upregulation of A-Raf or B-Raf, indicating other Raf family members mediate ERK activation downstream of TPO.\",\n      \"method\": \"raf-1-/- knockout mouse megakaryocyte analysis, TPO stimulation assays, western blot for ERK phosphorylation and Raf isoforms, ploidy analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with multiple orthogonal readouts definitively excluding Raf-1 from TPO-ERK pathway\",\n      \"pmids\": [\"14576068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In vitro enzyme activity assays of TPO (thyroid peroxidase) missense mutations show that residual TPO enzymatic activity correlates with clinical severity: patients with <15% residual activity show severe congenital hypothyroidism, while those with >16% show mild phenotypes.\",\n      \"method\": \"In vitro TPO enzyme activity assays of mutant constructs, genotype-phenotype correlation in 230 Chinese CH patients\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzyme assay with multiple mutants and clinical correlation, single lab\",\n      \"pmids\": [\"32088313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Iodination of proteins by thyroid peroxidase (TPO) in thyroid cancer cells is strictly dependent on TPO enzymatic activity and independent of NIS (sodium-iodide symporter) function; co-expression of TPO and NIS shows organification requires TPO but not iodide uptake via NIS.\",\n      \"method\": \"Stable transfection of TPO and NIS constructs, 125I organification assays, specific inhibitors of TPO and NIS\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct enzyme assay with specific inhibitors establishing TPO as the organification catalyst independent of NIS\",\n      \"pmids\": [\"15062578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Lnk deficiency leads to increased TPO signaling and increased osteoclastogenesis; Lnk is expressed in osteoclast lineage cells and Lnk-/- osteoclast progenitors cultured with TPO produce significantly more osteoclasts than WT, establishing a direct role of TPO/c-Mpl/Lnk signaling in bone remodeling.\",\n      \"method\": \"Lnk-/- mouse bone phenotype analysis (microCT, histomorphometry), in vitro osteoclast differentiation with TPO, alkaline phosphatase assays in osteoblasts\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined bone phenotype plus direct in vitro osteoclastogenesis assay, single lab\",\n      \"pmids\": [\"28067429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TPO (thyroid peroxidase) expressed in breast tissue has enzymatic activity and isoelectric point comparable to thyroid TPO, but with decreased glycosylation and slightly lower molecular weight. In mammary cell lines, TPO is mainly cytoplasmic with insufficient cell-surface expression to detect enzymatic activity, and no dimer formation occurs.\",\n      \"method\": \"Western blot, enzymatic activity assays, isoelectric focusing, immunohistochemistry, panel of TPO-specific antibodies in breast tissue and cell lines\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods characterizing TPO biochemistry in non-thyroid context, single lab\",\n      \"pmids\": [\"29513734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"During megakaryocytic differentiation of UT-7/TPO cells, TPO induces upregulation of PDGFR-α and PDGFR-β and promotes formation of PDGFRαβ heterodimer complexes and complexes between PDGFRs and neuropilin-1 (NRP-1), suggesting NRP-1 participates in megakaryopoiesis through PDGFR interactions.\",\n      \"method\": \"Co-immunoprecipitation, western blot, immunocytochemistry in UT-7/TPO cells stimulated with TPO and PMA\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP study identifying complex formation, single lab, no functional rescue\",\n      \"pmids\": [\"25744030\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Thrombopoietin (TPO) binds its receptor c-Mpl to activate JAK2, which phosphorylates receptor tyrosines recruiting STAT3/STAT5, Gab1/2-PI3K-Akt, and Ras-MAPK signaling cascades; the adaptor Lnk negatively regulates this pathway via its SH2 domain; TPO protein levels and JAK2/MPL expression levels together determine whether downstream signaling drives megakaryocyte proliferation versus differentiation, while thyroid peroxidase (TPO) is a heme-containing enzyme whose cryo-EM structure reveals a four-domain monomer with a disulfide-fixed architecture, and whose catalytic histidines (His239/His494) and organification activity are essential for thyroid hormone biosynthesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"The gene symbol TPO maps to two distinct genes: thrombopoietin (THPO) and thyroid peroxidase (TPO). Thrombopoietin is the primary cytokine regulating megakaryopoiesis and platelet production; it binds the c-Mpl receptor to activate JAK2, which phosphorylates STAT3/STAT5 and recruits Gab1/2–PI3K–Akt and Ras–MAPK cascades, with the adaptor Lnk acting as a negative regulator through its SH2 domain, and circulating TPO levels are homeostatically controlled by platelet mass via c-Mpl-mediated uptake [PMID:7544303, PMID:9474742, PMID:15337790, PMID:11402314]. The relative expression levels of JAK2 and MPL determine whether TPO signaling drives megakaryocyte proliferation or differentiation, and TPO additionally promotes hematopoietic stem cell self-renewal through p38 MAPK–USF-1–Hoxb4 induction [PMID:25143485, PMID:12855555]. Thyroid peroxidase is a heme-containing enzyme essential for thyroid hormone biosynthesis that catalyzes iodide organification independently of NIS; its cryo-EM structure reveals a four-domain monomer with catalytic histidines His239 and His494, and loss-of-function mutations causing residual activity below ~15% result in severe congenital hypothyroidism [PMID:36537574, PMID:15062578, PMID:32088313].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Identification of JAK2–STAT5/STAT3 and Ras pathway activation downstream of TPO/c-Mpl established the core signaling framework through which thrombopoietin controls megakaryocyte biology.\",\n      \"evidence\": \"Immunoprecipitation and phosphorylation assays in hematopoietic cell lines showing TPO-induced phosphorylation of JAK2, STAT5, STAT3, Shc, Sos, Vav, and c-Cbl\",\n      \"pmids\": [\"7544303\", \"7488109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of each downstream pathway to proliferation vs. differentiation was not resolved\", \"Identity of direct JAK2 substrates on c-Mpl cytoplasmic tail not mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"TPO and c-mpl knockout mice demonstrated that TPO is the dominant non-redundant regulator of megakaryopoiesis and platelet production, and that circulating TPO is homeostatically regulated by platelet mass through receptor-mediated uptake.\",\n      \"evidence\": \"Genetic knockout mice showing 90% platelet reduction, reduced progenitors, decreased megakaryocyte ploidy, and inverse relationship between platelet mass and TPO levels\",\n      \"pmids\": [\"9474742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of hepatic production vs. other tissue sources of TPO not fully dissected\", \"Whether residual 10% platelet production depends on alternative cytokines was unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Sequence-based analysis of thyroid peroxidase identified the catalytic proximal (His494) and distal (His239) histidines and predicted why the TPO-2 splice variant lacking Asn579 is enzymatically inactive.\",\n      \"evidence\": \"Sequence alignment of TPO with myeloperoxidase and multi-species peroxidases, comparative analysis of TPO vs. TPO-2 splice variant\",\n      \"pmids\": [\"9510129\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct mutagenesis was performed in this study to validate the histidine assignments\", \"Structural basis remained computational inference without experimental structure\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapping of Gab1/2 recruitment to c-Mpl phospho-Y112 and its requirement for PI3K/Akt activation resolved how TPO couples to the pro-proliferative PI3K pathway through a specific receptor tyrosine.\",\n      \"evidence\": \"Co-immunoprecipitation and Y112 site-directed mutagenesis in UT7 and Ba/F3 cells with PI3K activity and proliferation assays\",\n      \"pmids\": [\"11402314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other receptor tyrosines contribute to PI3K activation was not excluded\", \"Structural basis for Gab1/2 recognition of pY112 not determined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"TPO was linked to hematopoietic stem cell self-renewal through p38 MAPK–USF-1–Hoxb4 induction, extending TPO function beyond megakaryopoiesis to multipotent progenitor maintenance.\",\n      \"evidence\": \"Gene expression analysis in EML and UT-7/TPO cells, tpo−/− mouse comparison, p38 inhibition and USF-1 induction assays\",\n      \"pmids\": [\"12855555\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Hoxb4 induction is the sole mediator of TPO-driven HSC expansion was untested\", \"Single laboratory finding\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Thyroid peroxidase was confirmed as the obligate catalyst for iodide organification, functioning independently of the sodium-iodide symporter NIS.\",\n      \"evidence\": \"Stable transfection of TPO and NIS constructs with 125I organification assays and specific inhibitors in thyroid cancer cells\",\n      \"pmids\": [\"15062578\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only tested in cancer cell line context, not primary thyrocytes\", \"Coupling between NIS-mediated iodide transport and TPO at the apical membrane not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of Lnk as a negative regulator of TPO/c-Mpl signaling, acting through its SH2 domain to attenuate STAT3, STAT5, Akt, and MAPK pathways, revealed a key feedback control node in megakaryopoiesis.\",\n      \"evidence\": \"Lnk overexpression and knockout mice, western blot, megakaryocyte culture, domain mutagenesis\",\n      \"pmids\": [\"15337790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding partner of Lnk SH2 domain on c-Mpl or JAK2 not mapped\", \"Lnk regulation of other cytokine receptors not distinguished from TPO-specific effects\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Dissection of PI3K–Akt–mTOR versus MEK–ERK pathways showed that mTOR is required for TPO-induced polyploidization while MEK opposes it, clarifying how a single cytokine directs both proliferation and endomitotic differentiation.\",\n      \"evidence\": \"Pharmacological inhibition (rapamycin, PD98059) in CD34+ cell-derived megakaryocyte cultures with ploidy analysis\",\n      \"pmids\": [\"16449323\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pharmacological inhibitors lack complete specificity\", \"Direct mTOR substrates mediating polyploidization not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"NMR structural characterization of the c-Mpl transmembrane and juxtamembrane region in complex with a small-molecule agonist revealed a two-helix architecture and identified His-499 as a critical contact, providing a structural basis for non-peptide TPO mimetics.\",\n      \"evidence\": \"Solution and solid-state NMR, domain swap and site-directed mutagenesis of c-Mpl\",\n      \"pmids\": [\"17369254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length receptor structure with native TPO ligand not determined\", \"Whether the small-molecule activation mechanism fully mimics TPO-induced conformational change was unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstration that JAK2 and MPL expression levels gate the proliferation-versus-differentiation decision resolved the paradox of how graded TPO signaling generates distinct megakaryocyte fates.\",\n      \"evidence\": \"shRNA knockdown of JAK2/MPL, JAK2 chemical inhibitors in UT7-MPL cells, patient sample analysis, in vivo mouse studies\",\n      \"pmids\": [\"25143485\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative thresholds for the switch not precisely defined\", \"Whether this applies to HSC compartment or only committed megakaryocyte progenitors unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Genotype-phenotype correlation for thyroid peroxidase missense mutations established that residual enzymatic activity below ~15% causes severe congenital hypothyroidism, directly linking TPO catalytic function to disease severity.\",\n      \"evidence\": \"In vitro TPO enzyme activity assays of mutant constructs correlated with clinical phenotypes in 230 Chinese congenital hypothyroidism patients\",\n      \"pmids\": [\"32088313\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Activity measurements in vitro may not fully reflect in vivo folding and trafficking\", \"Cohort from single ethnic background\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Cryo-EM structures of human thyroid peroxidase resolved its four-domain architecture, heme environment, and autoantibody epitope locations, providing the first near-atomic model of this enzyme.\",\n      \"evidence\": \"Cryo-EM of purified hTPO–Fab complexes at 3.4–3.92 Å resolution\",\n      \"pmids\": [\"36537574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of TPO in complex with thyroglobulin substrate not determined\", \"Catalytic mechanism of iodination not captured at atomic detail in transition-state analogs\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for TPO (thrombopoietin) binding to full-length c-Mpl and the conformational changes that discriminate proliferative from differentiative signaling remain unresolved; for thyroid peroxidase, the mechanism of substrate (thyroglobulin) recognition and coupling reaction at the apical membrane has not been structurally characterized.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length TPO–c-Mpl complex structure exists\", \"Structural basis for thyroglobulin coupling by thyroid peroxidase is unknown\", \"How TPO signaling strength is quantitatively decoded into distinct transcriptional programs is mechanistically unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [13, 14, 19, 20, 22]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 2, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2, 11]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13, 20, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4, 6, 8, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 17]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [2, 11]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [13, 19, 20]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 6, 9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MPL\",\n      \"JAK2\",\n      \"STAT5\",\n      \"STAT3\",\n      \"LNK\",\n      \"GAB1\",\n      \"GAB2\",\n      \"TNS2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}